Publicaciones en colaboración con investigadores/as de University of Sydney (84)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Combining diaries and accelerometers to explain change in physical activity during a lifestyle intervention for adults with prediabetes: A PREVIEW sub-study

    PLoS ONE, Vol. 19, Núm. 3 March

  3. Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

    The Lancet Oncology, Vol. 25, Núm. 8, pp. e374-e387

  4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  5. Hybrid Evaluation of a Lifestyle Change Program to Prevent the Development of Type 2 Diabetes Among Individuals With Prediabetes: Intended and Observed Changes in Intervening Mechanisms

    Journal of primary care & community health, Vol. 15

  6. Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

    British Journal of Surgery, Vol. 111, Núm. 1

  7. Role of Eating Behavior and Stress in Maintenance of Dietary Changes During the PREVIEW Intervention

    Journal of Nutrition Education and Behavior, Vol. 56, Núm. 5, pp. 276-286

  8. Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

  9. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

    Ophthalmology, Vol. 131, Núm. 8, pp. 914-926

  10. Technical considerations for isolated limb perfusion: A consensus paper

    European Journal of Surgical Oncology, Vol. 50, Núm. 6

  11. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

    Matrix Biology, Vol. 132, pp. 1-9